2530.HK

Shares of nutritional products distributor Numans Health Food Holdings Co. Ltd. (2530.HK) opened down 1.3% in their Hong Kong trading debut on Friday from their offer price of HK$0.80. The stock continued to slide during the morning trading session, closing at HK$0.65 by the midday break, down 18.75%.

Numans announced it sold 250 million shares to raise net proceeds of HK$121 million ($15.55 million). The Hong Kong portion of the offering was 65.17 times subscribed, while the international placement was slightly oversubscribed.

The majority of Numans’ revenue comes from its sales of algal oil DHA products, accounting for over 90% of its total revenue. Its target consumers include pregnant and postpartum women, as well as infants and children. In the first half of 2024, the company reported revenue of HK$146 million, down 23.9% year-on-year, with net profit down 42% to HK$45.28 million.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Goodbaby makes strollers

Investors left crying as U.S. tariffs hit Goodbaby

The world’s leading producer of baby strollers and car seats is getting socked by a double whammy of U.S. tariffs and China’s baby bust Key Takeaways: Goodbaby reported its revenue…
Seeking a profile boost, Boxihe pivots to Hong Kong IPO

Seeking a profile boost, Boxihe pivots to Hong Kong IPO

The maker of high-performance outdoor clothing is betting on rising demand for its Pelliot apparel range in China’s still relatively untapped market   Key Takeaways: The company’s pre-IPO backers include Tencent…
Damai sells concert tickets

Damai rides China’s offline leisure boom to bumper profits

The company’s dominance in live entertainment ticketing and IP franchises has turbocharged its revenue, despite persistent consumer complaints and monopolistic behavior Key Takeaways: Damai’s profit rose around 50% in the…